CSPC Pharmaceutical (01093) said its profit attributable to shareholders for the nine months ended 30 September 2015 rose 35.1% year-on-year to HK$1,243 million.
Basic and diluted earnings per share were HK21.04 cents and HK20.81 cents.
The revenue was HK$8,503 million, an increase of 4.5% from a year earlier.
No dividend will be distributed for the reporting period.
全新節目《說說心理話》青少年不可以戀愛!?真實個案講述驚心動魄經歷► 即睇